Skip to main content
  • 882 Accesses

Abstract

Scleromyxedema is a cutaneous condition that is associated with paraproteinemia in more than 80% of cases (1). In the vast majority of cases, the paraprotein is an IgG heavy chain and a γ light chain. Rare cases of к light chains have been reported, and polyclonal hypergammopathy is also seen in some cases. It has been reported that only 10% of patients with scleromyxedema and associated monoclonal gammopathy will progress to multiple myeloma (1). Overall, scleromyxedema is associated with an increased mortality rate, probably due to the manifold systemic associations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dineen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995; 33: 37–43.

    Article  Google Scholar 

  2. Alberts AS, Schulz EJ, Falkson G, Simson IW, Coccia-Portugal MA. Normalization of skin appearance in a patient with scleromyxedema after intensive chemotherapy for Hodgkin’s disease. Dermatologica 1989; 178: 221–224.

    Article  PubMed  CAS  Google Scholar 

  3. Webster GF, Matsuoka LY, Burchmore D. The association of potentially lethal neurologic syndromes with scleromyxedema (popular mucinosis). J Am Acad Dermatol 1993; 28: 105–108.

    Article  PubMed  CAS  Google Scholar 

  4. Rongioletti F, Rebora A. Updated classification of popular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273–281.

    Article  PubMed  CAS  Google Scholar 

  5. Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: A scleroderma-like disorder with systemic manifestations. Medicine (Baltimore) 1988: 67: 58–65.

    CAS  Google Scholar 

  6. Gottron HA. Skleromyxedema. Arch Dermatol Syphilol 1954; 199: 71–91.

    Article  CAS  Google Scholar 

  7. Chanda JJ. Scleromyxedema. Cutis 1979; 24: 549–552.

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

(2007). Scleromyxedema. In: Deadly Dermatologic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68858-9_22

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-68858-9_22

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-25442-5

  • Online ISBN: 978-0-387-68858-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics